Literature DB >> 10451062

Work disability in rheumatoid arthritis 10 years after the diagnosis.

T Sokka1, H Kautiainen, T Möttönen, P Hannonen.   

Abstract

OBJECTIVE: To describe employment status of patients with early rheumatoid arthritis (RA) 10 years after diagnosis; and to identify predictive and associative factors related to permanent work disability.
METHODS: The study population consisted of 82 patients with early RA who were gainfully employed at onset of RA. Patients were prospectively followed for an average of 10 years and were treated according to the "sawtooth" strategy.
RESULTS: After a time since diagnosis of 2 and an average of 9.9 years, respectively, 19/82 (19%) and 36/82 (44%) cases have been retired merely or partly due to RA. Further, at the latest checkup 42/82 (51%) patients were still gainfully employed, while the prevalence of patients working full time under the common retirement age of 65 yrs was 58% (42/72). Cox regression analysis revealed that physically heavy work at baseline was the strongest independent predictive factor for permanent work disability. Ten years after disease onset, however, work disabled patients had more severe disease than those who continued in work.
CONCLUSION: Our study confirms that the working capacity of patients with RA is in danger from the very start. Despite early and active therapy with disease modifying antirheumatic drugs, at 10 years the cumulative work disability prevalence was 44%.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10451062

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  37 in total

1.  Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologists.

Authors:  J Sany; P Bourgeois; A Saraux; S Durieux; A Lafuma; J P Daurès; F Guillemin; J Sibilia
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

Review 2.  Predictive factors of work disability in rheumatoid arthritis: a systematic literature review.

Authors:  E M de Croon; J K Sluiter; T F Nijssen; B A C Dijkmans; G J Lankhorst; M H W Frings-Dresen
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 3.  Racial and ethnic disparities in rheumatoid arthritis.

Authors:  Christine A McBurney; Ernest R Vina
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

4.  Assessment of the treat-to-target strategy in patients with refractory rheumatoid arthritis. A prospective study on efficacy and safety in a Saudi population.

Authors:  R H A Mohammed; H H Kewan; M Bukhari
Journal:  Z Rheumatol       Date:  2014-10       Impact factor: 1.372

5.  [Arthroplasty of the rheumatoid hand. Pre- and postoperative imaging with special consideration of biomechanical and pathobiomechanical aspects and its radiological evaluation].

Authors:  O J Sommer; K Sekyra
Journal:  Radiologe       Date:  2006-09       Impact factor: 0.635

6.  Reliability of the ICF Core Set for rheumatoid arthritis.

Authors:  Till Uhlig; Solvår Lillemo; Rikke Helene Moe; Tanja Stamm; Alarcos Cieza; Annelies Boonen; Petter Mowinckel; Tore Kristian Kvien; Gerold Stucki
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

7.  Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D.

Authors:  Jinoos Yazdany; R Adams Dudley; Randi Chen; Grace A Lin; Chien-Wen Tseng
Journal:  Arthritis Rheumatol       Date:  2015-06       Impact factor: 10.995

8.  Severity of rheumatoid arthritis: the SEVERA study.

Authors:  Rafic Baddoura; Souha Haddad; Hassane Awada; Abdel Fattah Al-Masri; Georges Merheb; Said Attoui; Jad Okais; Jamil Messayke; Fadi Ghandour
Journal:  Clin Rheumatol       Date:  2005-12-15       Impact factor: 2.980

9.  Work factors and behavioural coping in relation to withdrawal from the labour force in patients with rheumatoid arthritis.

Authors:  A M Chorus; H S Miedema; C W Wevers; S van der Linden
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

10.  Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol.

Authors:  Johanna M Hazes; Peter Taylor; Vibeke Strand; Oana Purcaru; Geoffroy Coteur; Philip Mease
Journal:  Rheumatology (Oxford)       Date:  2010-06-14       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.